Tracey Marantal Takes Charge as Head of Oncology at Worldwide
Tracey Marantal has been appointed as the President of the Oncology Business Unit at Worldwide Clinical Trials, a leading contract research organization (CRO) that provides extensive services on a global scale. With more than twenty years in clinical operations, including over fifteen years focused on oncology, Marantal is poised to elevate and steer the company's oncology portfolio in this pivotal time for cancer research.
The Changing Landscape of Oncology Research
The oncology field is rapidly evolving, driven by breakthroughs in precision medicine, immunotherapy, and targeted treatments. With the increasing incidence of cancer, the significance of innovative and effective clinical trials is more important than ever. Marantal's leadership is set to strengthen Worldwide’s dedication to offering state-of-the-art oncology solutions, improving their responsiveness to changing customer needs.
Driving Growth in Oncology
With Marantal at the helm, Worldwide Clinical Trials looks to enhance collaborations with sponsors, tailoring research to support advanced stages of vital treatments. The emphasis will be on increasing customer engagement through a compassionate and adaptable approach, while leveraging specialized oncology experts to navigate the complexities of clinical trials.
A Proven Leader in Clinical Trials
“Tracey brings extensive knowledge of both small and large molecule treatments, along with her skills in precision oncology, diagnostics, and biomarker research. Her comprehensive understanding of complex trial designs and regulatory requirements is an immense advantage for our team,” noted Dave Bowser, Chief Operating Officer at Worldwide. He highlighted that Marantal’s successful history will be essential as Worldwide partners with pharmaceutical and biotech firms to enhance oncology practices.
Dedication to Patient-Centric Clinical Research
Marantal expressed her enthusiasm about joining Worldwide, sharing, “The future of cancer treatment hinges on our ability to orchestrate highly complex clinical trials that focus on patient needs. I'm dedicated to contributing to this innovative mission and effectively supporting our partners and patients.”
Building effective teams has been a hallmark of Marantal’s career. Before joining Worldwide, she held the position of Vice President of Clinical Operations at Zai Laboratory, where she concentrated on developing global strategies and nurturing collaborations with leading industry figures and clinical sites. Her previous roles at Genentech/Roche, Bristol Myers Squibb, and ICON have enriched her expertise, enabling her to significantly influence the advancement of cancer treatments.
Worldwide Clinical Trials: A Leader in Research
Worldwide Clinical Trials is well-regarded for its commitment to collaborating with biopharmaceutical companies, advancing new treatments from research to clinical stages. Their diverse capabilities cover clinical trials of all phases, bioanalytical laboratory services, and comprehensive real-world evidence studies, all backed by a skilled and varied team. Their therapeutic focus spans several crucial areas, including oncology, neuroscience, rare diseases, and cardiometabolic conditions.
For more information on Worldwide’s extensive oncology experience, you can check their offerings on their official website.
Frequently Asked Questions
What is Tracey Marantal's role at Worldwide Clinical Trials?
Tracey Marantal serves as the President of the Oncology Business Unit, leading oncology research initiatives at Worldwide Clinical Trials.
What are Worldwide's main focuses in the oncology sector?
Worldwide prioritizes personalized, flexible research strategies and collaborates with sponsors to improve cancer treatment solutions.
What experience does Tracey Marantal bring to her position?
She has over 20 years of experience in clinical operations, with significant expertise in oncology and precision medicine.
How is Worldwide Clinical Trials positioned in the research market?
Worldwide is a full-service CRO that offers tailored clinical research solutions, particularly in oncology, fostering therapeutic innovation.
Why are clinical trials essential for cancer research?
Clinical trials are crucial for advancing new and effective cancer treatments, meeting the evolving needs of patients around the world.
